HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emile Voest Selected Research

Emile Voest Research Topics

Disease

17Neoplasms (Cancer)
04/2024 - 09/2002
3Breast Neoplasms (Breast Cancer)
01/2023 - 12/2007
3Adenocarcinoma
01/2014 - 09/2002
1Lung Neoplasms (Lung Cancer)
04/2024
1Neoplasm Metastasis (Metastasis)
03/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2015
1Residual Neoplasm
08/2012
1Triple Negative Breast Neoplasms
08/2012
1Prostatic Neoplasms (Prostate Cancer)
08/2003
1Anemia
08/2003

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 08/2012
1pembrolizumabIBA
04/2024
1Immune Checkpoint InhibitorsIBA
04/2024
1human ERBB2 proteinIBA
01/2023
1Ado-Trastuzumab EmtansineIBA
01/2023
1Immunoconjugates (Immunoconjugate)IBA
01/2023
1Biosimilar PharmaceuticalsIBA
01/2018
1Proteins (Proteins, Gene)FDA Link
03/2016
1N-acetyltalosaminuronic acid (NAT)IBA
01/2016
1Prednisolone (Predate)FDA LinkGeneric
04/2015
1Cetuximab (Erbitux)FDA Link
01/2014
1ParaffinIBA
08/2012
1Formaldehyde (Formol)FDA Link
08/2012
1Endothelin Receptor AntagonistsIBA
08/2003
1Endothelins (Endothelin)IBA
08/2003
1AtrasentanIBA
08/2003
1Hormones (Hormone)IBA
08/2003
1matrigelIBA
09/2002
1Hemoglobins (Hemoglobin)IBA
09/2002
1Platelet Endothelial Cell Adhesion Molecule-1IBA
09/2002

Therapy/Procedure

8Therapeutics
04/2024 - 08/2003
3Immunotherapy
01/2019 - 01/2016
2Precision Medicine
01/2020 - 01/2020
1Radiotherapy
01/2014
1Drug Therapy (Chemotherapy)
01/2014
1Aftercare (After-Treatment)
08/2012
1Adjuvant Chemotherapy
12/2007
1Hemodilution
08/2003